Allelopathy Journal is indexed in SCOPUS, Web of Science, BIOSIS and UGC Approved. It is the only Journal exclusively publishing Allelopathy Research papers. It has completed 66-Volumes till November 2025. It ensures quicker publication of your research using Print and Online Editions. The accepted papers are published within 60-90 days after submission. We aim to bring the highest quality research to the widest possible audience.

Expanded Scope Since 2023 In 2023, Allelopathy Journal broadened its horizons to encompass cutting-edge research on:

• Plant-Microbe-Animal Interactions: Exploring in-vivo and ecological dynamics.
• Health Innovations: Leveraging plant chemicals and microbial metabolites for immunity, cancer, and diabetes treatments.
• Biotechnological Advances: Enhancing metabolite production for pharmaceutical and agricultural applications.

Our bi-monthly issues now feature interdisciplinary studies, ensuring rapid dissemination of impactful discoveries.

• Global Reach: Indexed in SCOPUS, UGC Care List, with a NAAS Rating of 7.28, SNIP: 0.378, SJR: 0.248, CiteScore: 1.8, and Google Scholar metrics (h-index: 43, i10-index: 523).
• Rapid Publication: Manuscripts are published within 2-months of submission, supported by our esteemed editorial board led by Editor-in-Chief Prof. M. J. Reigosa (Spain).
• Rigorous Peer Review: Ensuring the highest standards of scientific integrity and innovation.
• Normal Publication Fee
• Certificate of Publication: Journal provides soft copy of ‘Certificate of Publication’ to Correspondence Author

KEY POINTS

• We publish quality research under Double-Blind Peer Review
• We provide soft copy of ‘Certificate of Publication’ to Correspondence Author
• High visibility and Impact to all researchers, Readers and students.
• Journal is multi-desciplinary and publish Allelopathy Research papers related to Plant and Health sciences.

FREQUENCY OF PUBLICATION: It is published bi-monthly (January, March, May, July, September, November), hence, the manuscripts will be published within 60-90 days after submission. The Allelopathy Journal has successfully completed 31 years of publication and has published 66 volumes till November 2025. The manuscript passes through 15 processing stages prior to publication. Manuscripts may be prepared as per INSTRUCTION TO AUTHORS given on our website (www.allelopathyjournal.com) and may be obtained from Prof. S.S. Narwal by mail at Chiefeditor@allelopathyjournal.com, allelopathy2017@gmail.com, narwals2017@gmail.com.

1. DOI: The Digital Object Identifier (DOI) is an identification system for intellectual property in the digital environment. Allelopathy Journal has collaboration with CrossRef for assigning DOI numbers. Every paper published in the journal from 2017 has been registered with a DOI number from CrossRef.
2. Allelopathy Journal is a highly specialised journal, only publishing allelopathy and related areas research in Plant Sciences and Health Sciences.
3. PUBLICATION SCHEDULE: It is bi-monthly, always published in time, never late.
4. QUICKER PUBLICATION: Manuscripts are published within 60-90 days after submission.
5. INTERNATIONAL REVIEW OF MANUSCRIPTS: It is done by eminent allelopathy scientists of our Editorial Board. Each manuscript is peer reviewed by two reviewers.
6. MANUSCRIPT PROCESSING STAGES: The manuscript passes through 15 processing stages before publication.
7. PUBLICATION CHARGES: Allelopathy Journal  is published by Allelopathy Books, a small self-supporting firm and does not receive funds from any institution/government. The current publication charges since 2020 (5-years) for manuscript publication in this journal are Euro 300.00 per 4 pages or part thereof (discounted charges in various countries based on Human Development Index), based on final pages to be published in the journal.

Hence the journal is solely financed by the publication charges received from authors. The publication charges are required to meet operational expenses (employees' salaries, internet services, electricity, phone bill, office rent, web hosting, production expenses) and article processing (professional copy editing, proof reading, etc.). It costs to produce a peer-reviewed, edited and formatted article for publication and to host it on a server that is accessible 24 - 7. We ask the author, institution or funding agency to pay a nominal publication fee (as compared to charges in Springer, Elsevier, PLOS ONE, etc. journals with similar impact factor) to help cover the actual cost of publication. Authors are required to pay only after their article's galley proof is ready for publication. Thereafter, a proforma invoice is issued for payment of publication charges based on the final number of pages to be printed in the journal.

Payment of these charges allows Allelopathy Books to recover its editorial and production costs. These charges are paid from the author's research budget, or by their institution. Before the research paper is published, it passes through 15 processing stages (involving our hard work and investment of valuable time and energy). We add value to your research; hence, we are entitled to charge for it. IT IS A NON-PROFIT ORGANIZATION. As per rules, the pre-payment of publication charges/APC is mandatory for publication of manuscripts. The publication charges include free online access of Allelopathy Journal for one year to the corresponding author, which is priced at Euro 400.00 per year.

The publication charges vary among countries based on the Human Development Index (HDI):
A. Developed countries: Euro 300.00 per 4 pages.
B. India: Rs. 3000.00 per 4 pages.
C. Discounted publication charges: Based on the economic status of these countries (b,c,d categories), publication charges are heavily discounted, so that researchers in these countries can also publish their research papers in Allelopathy Journal. Instead of separate charges for number of pages published plus figures, a bundle price for a complete research paper is offered as under:

(i). African countries: Euro 350.00-400.00 (except developed countries like South Africa).
(ii). Pakistan, Iran and neighbouring countries: Euro 300.00-350.00.

HUMAN DEVELOPMENT INDEX (HDI) COUNTRY-WISE - 2020.
a. Very highly developed countries, HDI rank 1-49: Andorra, Argentina, Australia, Austria, Bahrain, Belgium, Brunei Darussalam, Canada, Chile, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, Ireland, Israel, Italy, Japan, Kuwait, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, New Zealand, Norway, Poland, Portugal, Qatar, Saudi Arabia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, United Arab Emirates, United Kingdom, United States.

b. Highly developed countries, HDI rank 50-102: Albania, Algeria, Antigua and Barbuda, Armenia, Azerbaijan, Bahamas, Barbados, Belarus, Belize, Bosnia and Herzegovina, Brazil, Bulgaria, China, Colombia, Costa Rica, Dominica, Dominican Republic, Ecuador, Fiji, Georgia, Grenada, Iran, Jamaica, Jordan, Kazakhstan, Lebanon, Libya, Macedonia, Malaysia, Mauritius, Mexico, Montenegro, Oman, Palau, Panama, Peru, Romania, Russia, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Serbia, Seychelles, Sri Lanka, Suriname, Thailand, Tonga, Trinidad and Tobago, Tunisia, Turkey, Ukraine, Uruguay, Venezuela.

c. Medium developed countries, HDI rank 103-144: Bangladesh, Bhutan, Bolivia, Botswana, Cambodia, Cape Verde, Congo (Republic), East Timor, Egypt, El Salvador, Equatorial Guinea, Gabon, Ghana, Guatemala, Guyana, Honduras, India, Indonesia, Iraq, Kiribati, Kyrgyzstan, Lao, Maldives, Micronesia, Moldova, Mongolia, Morocco, Namibia, Nicaragua, Palestine, Paraguay, Philippines, Samoa, São Tomé and Príncipe, South Africa, Syria, Tajikistan, Turkmenistan, Uzbekistan, Vanuatu, Vietnam, Zambia.

d. Low developed countries, HDI rank 145-187: Afghanistan, Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo (Democratic Republic), Djibouti, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Ivory Coast, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Myanmar, Nepal, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Senegal, Sierra Leone, Sudan, Swaziland, Tanzania, Togo, Uganda, Yemen, Zimbabwe.

MANUSCRIPT PROCESSING STAGES: There are 15 processing stages in manuscript publication.

Manuscripts are invited from researchers, scientists and graduate students working on allelopathy.

The Allelopathy Journal is partly open access to make research articles available to researchers worldwide. The online open access is of two types:

(i) Paid Access: Provides access to archives (all volumes of Allelopathy Journal) plus the current year journal.

Annual personal and institutional online rates for the current year are:

• Personal: €400.00 per calendar year
• Institutional: €700.00 per calendar year

(ii) Free Online Access: After log-in, all old volumes of Allelopathy Journal are free open access except the current year, which is available only to bona fide allelopathy researchers.

Advantages of online access for authors: Online access provides visibility to published research and enhances indexing and retrieval power.

• High visibility and high availability: Accessibility of publications worldwide over the internet.
• Frequency of citation: Online publications are often more cited due to their high publicity and availability.
• Ease of access: Publications are easily accessible and searchable in search engines and indexing databases.

Please see the detailed information on Publication Charges.

From 2016, Allelopathy Journal is published six times in one calendar year: January, March, May, July, September, and November.

You will receive a letter of acceptance from the Chief/Associate Editor. If you have any doubt, please contact the Editorial Office at Chiefeditor@allelopathyjournal.com, allelopathy2021@gmail.com.

All accepted papers are subjected to final editing and copy-editing by the Chief Editor to ensure that articles conform to journal style and there are no spelling or grammatical errors, etc.

Before publication in the journal, the galley proofs are sent to authors by email for final corrections, if any.

The author's corrected galley proof is required within three working days, so that the journal is published on time.